首页> 外国专利> use of staurosporine derivatives as inhibitors of tyrosine kinase flt3 receptor activity in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndromes

use of staurosporine derivatives as inhibitors of tyrosine kinase flt3 receptor activity in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndromes

机译:星形孢菌素衍生物作为酪氨酸激酶flt3受体活性抑制剂在急性髓细胞白血病和高危骨髓增生异常综合征的治疗中的应用

摘要

"staurosporine derivatives as inhibitors of tyrosine kinase flt3 receptor activity". the present invention relates to the use of staurosporine derivatives for the preparation of a drug for the treatment of diseases involving the unregulated activity of flt3 tyrosine kinase receptors, especially for the curative and / or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving the unregulated activity of flt3 tyrosine kinase receptors.
机译:“星形孢菌素衍生物作为酪氨酸激酶flt3受体活性的抑制剂”。本发明涉及星形孢菌素衍生物在制备药物中的用途,该药物用于治疗涉及flt3酪氨酸激酶受体活性失调的疾病,特别是用于白血病和骨髓增生异常综合症的治疗和/或预防性治疗,并且涉及一种方法治疗涉及flt3酪氨酸激酶受体活性失调的疾病。

著录项

  • 公开/公告号BRPI0213739B1

    专利类型

  • 公开/公告日2020-06-09

    原文格式PDF

  • 申请/专利权人 DANA-FARBER CANCER INSTITUTE INC.;NOVARTIS AG.;

    申请/专利号BR2002PI13739

  • 发明设计人 JAMES DOUGLAS GRIFFIN;PAUL WILLIAM MANLEY;

    申请日2002-10-29

  • 分类号A61K31/535;C07D498/22;A61K31/155;A61K31/407;A61K31/55;A61K31/553;A61P19/08;A61P35/02;A61P43;C07D487/04;C07D487/14;C07D519;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号